Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer-Reference-Cited by-同舟云学术

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

Published:2000-03 Issue:3 Volume:11 Page:339-342
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Caponigro F.,Cornelia P.,Budillon A.,Bryce J.,Avallone A.,De Rosa V.,Ionna F.,Cornelia G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/3/339/19478382/11-3-339.pdf

Reference14 articles.

1. Overview of combined modality therapies for head and neck cancer;Dimery;J Natl Cancer Inst,1993

2. Pharmacokinetics, biodistribution and therapeutic efficacy of doxorubicin encapsulated in Stealth liposomes (Doxil);Working;J Liposom Res,1994

3. Sterically stabilized liposomes: Improvement in pharmacokinetics and antitumor therapeutic efficacy;Papahadjopoulos;Proc Natl Acad Sci USA,1991

4. Arrest of human lung tumor xenograft growth in SCID mice using doxorubicin encapsulated in sterically stabilised liposomes;Williams;Cancer Res,1993

5. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma;Goebel;Br J Cancer,1996

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AN UPDATED REVIEW OF STEALTH LIPOSOMES AND ITS ABILITY TO EVADE THE IMMUNE SYSTEM: A NEW FRONTIER IN CANCER CHEMOTHERAPY;International Journal of Applied Pharmaceutics;2024-05-07

2. Lauric acid-based thermosensitive delivery system for the treatment of head and neck squamous cell carcinoma;Journal of Drug Targeting;2024-03

3. Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy;Pharmaceutics;2022-01-03

4. Improved efficacy and safety of low-dose oxaliplatin/pegylated liposomal doxorubicin/S-1 regimen in advanced gastric cancer: a cohort study;Annals of Palliative Medicine;2021-12

5. Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders;Current Drug Metabolism;2021-06-17